VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000 | -96.2% | 348 | -95.1% | 0.00% | -95.3% |
| Q2 2020 | $262,000 | -13.2% | 7,132 | -31.0% | 0.04% | -4.4% |
| Q4 2019 | $302,000 | +9.0% | 10,330 | -16.3% | 0.04% | +21.6% |
| Q1 2019 | $277,000 | -10.9% | 12,348 | -16.2% | 0.04% | -22.9% |
| Q4 2018 | $311,000 | 0.0% | 14,727 | -12.3% | 0.05% | +17.1% |
| Q3 2018 | $311,000 | -94.9% | 16,785 | -93.9% | 0.04% | -95.6% |
| Q2 2018 | $6,125,000 | +33.4% | 274,525 | +31.4% | 0.93% | +33.3% |
| Q1 2018 | $4,593,000 | +3.5% | 208,941 | +9.5% | 0.70% | +6.1% |
| Q4 2017 | $4,436,000 | +66.9% | 190,865 | +64.9% | 0.66% | +41.7% |
| Q3 2017 | $2,658,000 | +10.3% | 115,755 | +5.8% | 0.46% | +16.9% |
| Q2 2017 | $2,409,000 | +30.6% | 109,425 | +35.2% | 0.40% | +17.2% |
| Q1 2017 | $1,845,000 | -8.8% | 80,907 | -16.4% | 0.34% | -21.0% |
| Q4 2016 | $2,024,000 | – | 96,726 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |